Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2007
11/22/2007US20070270429 Function Inhibitor of Effector Cell
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270412 Novel pharmaceuticals
11/22/2007US20070270409 Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease
11/22/2007US20070270338 prevention of cardiac cell death and prevention of cardiac tissue damage resulting from ischemic events in cardiac tissue; Cardiovascular disease such as angina, myocardial infarct (MI), and stroke
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070269538 Method for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
11/22/2007US20070269536 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals
11/22/2007US20070269527 Therapeutic agents for low HDL-cholesterolemia
11/22/2007US20070269513 Liver selective drug therapy
11/22/2007US20070269506 Oral Sustained Release Pharmaceutical Composition
11/22/2007US20070269486 Methods and Devices for Reducing Tissue Damage After Ischemic Injury
11/22/2007US20070269484 Drug-delivery stent formulations for restenosis and vulnerable plaque
11/22/2007US20070269477 Heart Treatment Method
11/22/2007US20070269427 Therapeutical Use of Anti-Myelin Associated Glycoprotein (Mag) Antibodies
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007DE102006021733A1 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung 3 Tetrazolylindazole and 3-Tetrazolylpyrazolopyridine and their use
11/22/2007CA2652866A1 Therapeutic compounds
11/22/2007CA2652483A1 Use of drospirenone for preventing high blood pressure in prehypertensive patients
11/22/2007CA2652388A1 New use of therapeutically useful peptides
11/22/2007CA2652274A1 Il-1.alpha. immunization induces autoantibodies protective against atherosclerosis
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2650515A1 Benzylamine derivatives as cetp inhibitors
11/21/2007EP1857817A1 Screening method
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857544A1 Pluripotent stem cell derived from cardiac tissue
11/21/2007EP1857457A2 Benzimidazole derivative and its use as AII receptor antagonist
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857450A1 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
11/21/2007EP1857447A1 Ppar-activating compound
11/21/2007EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857107A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion
11/21/2007EP1856114A1 Benzisoxazole derivatives
11/21/2007EP1856085A1 Flavonoid compounds and uses thereof
11/21/2007EP1856059A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
11/21/2007EP1856051A1 Amorphous lercanidipine hydrochloride
11/21/2007EP1855673A2 Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
11/21/2007EP1855661A1 Formulation for aviptadil
11/21/2007EP1623711B1 External patch containing estrogen and/or progestogen
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1474140B1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1356071B1 Genetically engineered herpes virus for the treatment of cardiovascular disease
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007EP1197226B1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
11/21/2007EP0981374B1 Sustained-release delayed gels
11/21/2007CN101076531A Carboxylic acid peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101076529A Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
11/21/2007CN101076518A 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides
11/21/2007CN101076352A Il-15 antigen array and its application
11/21/2007CN101076343A Use of A2A adenosine receptor agonists
11/21/2007CN101074447A Method for producing paeonin metabolite-I by short lactobacillin fermentation
11/21/2007CN101074415A Acanthopanax-root wine and its production
11/21/2007CN101074222A 3-substituted cumarin compound, its production, medicinal composition and use
11/21/2007CN101073668A Antibody compositions for selectively inhibiting vegf
11/21/2007CN101073666A Method for producing high-purity kallidin proenzyme raw-material medicine
11/21/2007CN101073653A Chinese-medicinal powder for treating acne
11/21/2007CN101073631A Medicine for treating posthemiplegic paralysis and coronary heart diesease
11/21/2007CN101073626A Treatment of acne
11/21/2007CN101073620A Acne cream and its production
11/21/2007CN101073618A Method for treating hypertension
11/21/2007CN101073617A Use of medicinal composition in treatment of micro-circulation handicap and prevention of stroke
11/21/2007CN101073604A Compound Chinese herb medicinal oral capsule for treating acne, anal cleft and anal fistual
11/21/2007CN101073599A Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
11/21/2007CN101073598A Medicinal composition for treating cardiovascular and cerebrovascular disease and its preparation
11/21/2007CN101073591A Medicinal composition for treating cardiovascular and cerebrovascular diseases
11/21/2007CN101073588A Capsule for treating coronary heart disease
11/21/2007CN101073568A Use of medicine for treating or preventing heart failure
11/21/2007CN101073567A Butylbenzene phthalein concentrated solution for injection and its making method
11/21/2007CN101073566A Production and use for tanshinone component injection
11/21/2007CN101073555A Injecting tanshinone II and its derivative concentrated solution and its production
11/21/2007CN101073429A Zanghonghua Chinese-medicinal beverage
11/21/2007CN101073364A Production of sweet-potato leaf health-care tea
11/21/2007CN101073363A Many-prickle acanthopanax root tea
11/21/2007CN101073361A Heart and brain health-care tea
11/21/2007CN101073357A Fat-lowering cardiotonic tea
11/21/2007CN100350053C Enzymatic synthesis method of 6-chloropurine riboside
11/21/2007CN100349915C Amido glycoside of sea pearl oyster, prepartion method, and usage
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349868C Novel indoline compound and medicinal use thereof
11/21/2007CN100349864C Treating syndrome X with substituted tetralins and indanes
11/21/2007CN100349856C Propionic acid derivatives and their use as hPPARs activators
11/21/2007CN100349568C Intravenous administered injection of ginkgolide B, its preparation method and application
11/21/2007CN100349567C (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007US7297761 Pharmaceutical compositions containing exendins
1 ... 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 ... 1595